F

Fennec Pharmaceuticals
D

FENC

9.93000
USD
-0.03
(-0.30%)
مغلق
حجم التداول
4,433
الربح لكل سهم
0
العائد الربحي
-
P/E
-34
حجم السوق
344,938,708
المقالات
المزيد

العنوان: Fennec Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.